Leukemia Clinical Trials

Showing 5781-5800 of 8,366 trials

SCT in Ph Positive Acute Lymphoblastic Leukemia

NCT03821727

This study includes a registry-based, nationwide analysis to describe the clinical outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) who underwent an allogeneic hematopoietic stem cell transplantation (HSCT) after a Tyrosine Kinase Inhibitors (TKI)-based treatment.

Philadelphia Positive Acute Lymphoblastic LeukemiaSCT

CANDONI ANNA441 participantsStarted Oct 2016

Genova, Italy • Udine, Italy

UNKNOWNPhase 1

A Phase 1b Study of STMC-103H in Multi-Sensitized Allergic Subjects Who Are Otherwise Healthy

NCT03819881

The primary objective of this study is to assess the safety and tolerability of STMC-103H compared to placebo in allergic subjects who are otherwise healthy.

Atopic Immunoglobulin E-Mediated Allergic Disorder

Siolta Therapeutics, Inc.60 participantsStarted Oct 2018

Stockton, California, United States • Tustin, California, United States

TERMINATEDPhase 1/2

Treatment of Elderly Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic (MD) Syndrome With Laromustine and Infusional Cytarabine

NCT00655395

* The purpose of the Phase I portion of this study is to evaluate the safety of this combination of medications and to determine the appropriate dose of VNP40101M to be used in combination with infusional cytarabine (araC) in elderly patients with Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS). * The purpose of the Phase II portion of the study is to evaluate the effectiveness (overall response rate) for patients treated with VNP40101M and infusional cytarabine induction therapy.

Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)

Viron Therapeutics Inc25 participantsStarted Mar 2008

New York, New York, United States

SCT in Ph Positive Acute Lymphoblastic Leukemia

A Phase 1b Study of STMC-103H in Multi-Sensitized Allergic Subjects Who Are Otherwise Healthy

Treatment of Elderly Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic (MD) Syndrome With Laromustine and Infusional Cytarabine

Related Searches

Efficacy and Safety of Endobiliary Radiofrequency Ablation by Using a Novel RF Catheter (ELRA®) on Maintaining the Patency of Endobiliary Metal Drainage in Patients With Malignant Biliary Strictures : A Double-arm Comparable Study

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

Nab-paclitaxel Combined With S-1 as Induction Therapy for Locally Advanced Pancreatic Cancer

GIMEMA CLL0809 Study (BendOfa)

Efficacy of Nasal Naphazoline Hydrocloride + Pheniramine Maleate + Panthenol Compared With Naphazoline Hydrocloride in the Symptomatic Control of Nasal Congestion and Nasopharyngeal

Palliative Care in the ICU

Red Cell Transfusion Goals in Patients With Acute Leukemias

Increase Surveillance for Wellness Decisions, Also to Determine Targeted Risk-reducing and Preventative Strategies

Diesel Exhaust Particles and Leukotriene Production

Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

What Difference do Chaplains Make: Analysis of Chaplain Interventions in Palliative Care in United Kingdom

The Efficacy and Drug Resistance Molecular Biology of Apatinib Combined With EGFR-TK1 Treated for Advanced Slow-progressed Non-Small Cell Lung Cancer (NSCLC)

GRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L)

Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation

SHR1020 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Squamous Non Small Cell Lung Cancer

Efficacy and Safety of SCT200 in Patients With Advanced Squamous Non-small Cell Lung Cancer

Heart Failure After Heart Transplantation Due to Chronic Rejection